Is Parabellum funding the plaintiff in a case that is being billed as ‘Bitcoin’s Trial of the Century’? More from Coingeek.
Dai Wai Chin Feman of Parabellum Capital counters views often expressed by property/casualty insurance organizations and explains why commercial litigation funding is not the root of social inflation. He offers data to show that the industry is too small to materially contribute to social inflation. In his view, regulation reforms being pushed by insurers and reinsurers would increase insurance costs and prolong case durations. He urges the insurance industry to embrace commercial funding as an opportunity for the development and expansion of new and existing business lines.
Parabellum is funding a proposed Canadian class action against over 50 generic drug manufacturers. The proposed class action alleges that the defendants conspired to “allocate the market, fix prices and maintain the supply of generic drugs” contrary to the Competition Act, and claims damages of $2.75 billion.
Claudia Linares Arciniegas has joined Parabellum Capital in New York as Director of International Arbitration and Litigation. Claudia was previously with Tenor Capital Management.